For: | Wei XC, Xia YR, Zhou P, Xue X, Ding S, Liu LJ, Zhu F. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J Gastroenterol 2021; 27(48): 8302-8322 [PMID: 35068871 DOI: 10.3748/wjg.v27.i48.8302] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i48/8302.htm |
Number | Citing Articles |
1 |
Yuan Fang, XiaoLi Zhang, HanFei Huang, Zhong Zeng. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04238-9
|
2 |
Ping Zhou, Wei Yao, Lijuan Liu, Qiujin Yan, Xiaobei Chen, Xiaocui Wei, Shuang Ding, Zhao Lv, Fan Zhu. SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma. Cellular Oncology 2024; 47(5): 1757 doi: 10.1007/s13402-024-00955-5
|
3 |
Hongyi Liu, Ruiyue Dang, Wei Zhang, Jidong Hong, Xuejun Li. SNARE proteins: Core engines of membrane fusion in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; : 189148 doi: 10.1016/j.bbcan.2024.189148
|
4 |
Jin Wang, Yali Yang, Jingyi Lu, Xia Wang. The role of exosomes in therapeutic resistance of hepatocellular carcinoma. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.85
|
5 |
Veronica Zelli, Chiara Compagnoni, Roberta Capelli, Alessandra Corrente, Mauro Di Vito Nolfi, Francesca Zazzeroni, Edoardo Alesse, Alessandra Tessitore. Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.940056
|
6 |
Adane Adugna. Histomolecular characterisation of hepatitis B virus induced liver cancer. Reviews in Medical Virology 2023; 33(6) doi: 10.1002/rmv.2485
|
7 |
Sun Sishuai, Gu Lingui, Li Pengtao, Bao Xinjie, Wei Junji. Advances in regulating endothelial-mesenchymal transformation through exosomes. Stem Cell Research & Therapy 2024; 15(1) doi: 10.1186/s13287-024-04010-w
|
8 |
Yingying Ding, Yong Zhang, Xuehong Liu. Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia. Frontiers in Molecular Neuroscience 2022; 15 doi: 10.3389/fnmol.2022.1043947
|
9 |
Ziyang Ye, Wenjie Chen, Genpeng Li, Jing Huang, Jianyong Lei. Tissue-derived extracellular vesicles in cancer progression: mechanisms, roles, and potential applications. Cancer and Metastasis Reviews 2024; 43(2): 575 doi: 10.1007/s10555-023-10147-6
|
10 |
Łukasz Ważny, Theresa L. Whiteside, Monika Pietrowska. Oncoviral Infections and Small Extracellular Vesicles. Viruses 2024; 16(8): 1291 doi: 10.3390/v16081291
|
11 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Extracellular Vesicles in Viral Liver Diseases. Viruses 2024; 16(11): 1785 doi: 10.3390/v16111785
|
12 |
Ming-He Zhang, Yu-Feng Yuan, Li-Juan Liu, Yu-Xin Wei, Wan-Yue Yin, Lan-Zhuo-Yin Zheng, Ying-Ying Tang, Zhao Lv, Fan Zhu. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(31): 4706-4735 doi: 10.3748/wjg.v29.i31.4706
Abstract(542) |
Core Tip(561) |
Full Article(HTML)(2561)
|
Full Article with Cover (PDF)-6652K(120)
|
Full Article (Word)-973K(26)
|
Audio-1688K(8)
|
Peer-Review Report-263K(56)
|
Answering Reviewers-79K(60)
|
Supplementary Material-253K(58)
|
Full Article (PDF)-1349K(194)
|
Full Article (XML)-569K(56)
|
Times Cited (6)
|
Total Visits (6665)
|
Open
|
13 |
Tian Zhang, Lingling Guan, Xiaomeng Xie, Lixing Guo, Dongjing Ni. Microrna-135A-5P promotes proliferation and metastasis of hepatocelluar carcinoma cells via upregulation of FOXO1. Brazilian Journal of Pharmaceutical Sciences 2024; 60 doi: 10.1590/s2175-97902024e23870
|
14 |
Ziyu Liu, Yanan Li, Yufeng Wang, Xinquan Bai, Ying Zhang. Exosomes in HBV infection. Clinica Chimica Acta 2023; 538: 65 doi: 10.1016/j.cca.2022.11.012
|
15 |
Lijuan Liu, Zhao Lv, Miao Wang, Dongyan Zhang, Dongying Liu, Fan Zhu. HBV Enhances Sorafenib Resistance in Hepatocellular Carcinoma by Reducing Ferroptosis via SRSF2-Mediated Abnormal PCLAF Splicing. International Journal of Molecular Sciences 2023; 24(4): 3263 doi: 10.3390/ijms24043263
|
16 |
聪聪 谭. Advances in the Diagnosis and Treatment of Exosomal miRNA in Liver Cancer. Advances in Clinical Medicine 2024; 14(05): 2093 doi: 10.12677/acm.2024.1451655
|
17 |
Hanjia Zhang, Xuanyi Liu, Jiuming Shi, Xuan Su, Jiayuan Xie, Qingfeng Meng, Hao Dong. Research progress on the mechanism of exosome-mediated virus infection. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1418168
|
18 |
Li-Juan Liu, Zhao Lv, Xing Xue, Zhong-Yuan Xing, Fan Zhu. Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy. Cancers 2022; 14(23): 5781 doi: 10.3390/cancers14235781
|
19 |
Man Yao, Shufang Liang, Binbin Cheng. Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1110922
|
20 |
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al-Hetty, Pushpamala Ramaiah, Alaa Hameed Fazaa, Abduladheem Turki Jalil, Fahad Alsaikhan, Jitendra Gupta, Andrés Alexis Ramírez-Coronel, Nahla A. Tayyib, Hu Peng. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint. Environmental Research 2023; 227: 115683 doi: 10.1016/j.envres.2023.115683
|
21 |
Xiaojing Wu, Junqi Niu, Ying Shi. Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02544-y
|
22 |
Zhao Lv, Lijuan Liu, Jian You, Ping Zhou, Yaru Su, Kexin Zhao, Jiahang Zhang, Fan Zhu. Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429‐dependent m6A modification of CCR9. Journal of Medical Virology 2024; 96(9) doi: 10.1002/jmv.29894
|